Skip to content

Dr. Carmen Noordman

Active Private limited companyfounded 2020active for 6 yearsGloriantlaan 51, 2050 AntwerpKBO/BCE: BE 0754.394.437

Lifetime

5 annual accounts with figures on one time axis
peak of €125,727 in 2024
€103,918▼ 17.3%
peak of €97,537 in 2024
€70,875▼ 27.3%
peak of €219,026 in 2023
€72,875▼ 26.8%
€328,429▲ 37.1%
Board1 name since 2020
1 director
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Gross margin from €125,727 to €103,918Result from €97,537 to €70,875Dividend €97,537Equity from €99,537 to €72,875Debts from €239,468 to €328,429Investments €109,196

Key points

from the 2025 annual accounts

Equity

€72,875 from €219,026 in 2023

Equity fell by 67% in 2 years.

Turnover

≈ €190,000 estimated

The micro format states no turnover.

Debts

€328,429 82% of the balance sheet
Financial debts 8%Suppliers 1%Taxes and wages 3%Other 88%

Of this, €287,657 falls due within a year.

Investments

€109,196 58.2 times depreciation
2021202220232025

Green is investment, beige is depreciation.

Filings

5 annual accounts 4 late
AprilJune31 JulyOctober20222024

The 2021 accounts came in latest, 91 days after the end of the period.

Position in the sector

18.2%

Lower solvency than 81% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,713 companies had the same profile as Dr. Carmen Noordman has now. Each dot stands for 17 companies, two years later.

95.8%
were still trading
2.2%
stopped another way
1.9%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,713 companies, not a prediction for Dr. Carmen Noordman. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • founderdeed of 16-09-2020
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0754394437
Registered office moved from Beveren to Antwerp The registered office moved from Spoorweglaan 91, 9120 Beveren to Glorlantlaan 51, bus 13, 2050 Antwerpen · Gazette deed
Incorporation Founded by · 100 shares · appointed as director · published on 16-09-2020 · Gazette deed
First establishment At the time the registered office was still in Beveren, Spoorweglaan 91.
All 13 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Carmen Noordman Antwerp €401,305 €103,918 18.2% -
Dr. Herregodts P. Antwerp €414,457 €108,541 -3.1% -
Dokter Torfs Antwerp €387,717 €108,062 8.1% -
DOCTEUR JULIEN MICHEL Floreffe €422,993 €105,738 23.7% -
Dr. Driesens Ans Tielt €420,353 €104,974 79.4% -
KAMANOU HEALTH Ganshoren €459,903 €100,106 6.4% -
DR. MAARTEN CUELENAERE BV Assenede €436,020 €113,562 89.7% -

These companies have the same main activity as Dr. Carmen Noordman: general medical practice (NACE 86210). They are comparable in size and age: total assets between €388,000 and €460,000, founded between 2020 and 2021.

Official details

Source: KBO
Status
Active since 14-09-2020Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.308.282.1752050 Antwerp, registered on 14-09-2020
Financial year end
31 December
Peppol
Reachable since 21-01-2025
Company details

Annual accounts 2025

€401,305▲ 18.4%
Filing
Filed on 31-08-2026
Financials

Insights on Dr. Carmen Noordman

Dr. Carmen Noordman files the micro format. That format states no turnover. The gross margin fell from €109,241 in 2021 to €103,918 in 2025.

The balance sheet grew most from 2023 to 2025 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Carmen Noordman

What is the company number of Dr. Carmen Noordman?
The company number of Dr. Carmen Noordman is 0754.394.437. The VAT number is the same number with BE in front: BE 0754.394.437.
Where is Dr. Carmen Noordman based?
The registered office is at Gloriantlaan 51, 2050 Antwerp.Company details
What does Dr. Carmen Noordman do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Carmen Noordman?
Dr. Carmen Noordman is a private limited company (BV).
When was Dr. Carmen Noordman founded?
Dr. Carmen Noordman was founded on 14-09-2020.
Is Dr. Carmen Noordman still active?
Yes, Dr. Carmen Noordman is an active enterprise in the KBO register.
What is the turnover of Dr. Carmen Noordman?
The turnover in financial year 2025 is about €190,000. This figure is estimated from the gross margin of €103,918 and 30 comparable companies (NACE 86210). It probably lies between €150,000 and €240,000.Financials
Is Dr. Carmen Noordman profitable?
In financial year 2025, Dr. Carmen Noordman made a profit of €70,875.
Where can I find the annual accounts of Dr. Carmen Noordman?
Dr. Carmen Noordman filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Carmen Noordman due?
Dr. Carmen Noordman must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.